Why IV labetalol may fail to control blood pressure in severe preeclampsia
Part of Women’s health & pregnancy clinical trials.
This study looks at how well the intravenous (IV) medicine labetalol lowers blood pressure in women with severe preeclampsia, a serious pregnancy complication. It aims to identify which patients might need different or additional treatment to control their blood pressure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are at least 24 weeks pregnant (with one or more babies).
- You have severe preeclampsia (a serious pregnancy complication with high blood pressure) and need the IV medicine labetalol to control it.
- You do not have any condition that makes labetalol unsafe for you (like asthma, COPD, slow heart rate, heart block, or a past allergic reaction to it).
- You have not already started IV blood pressure treatment before joining this study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at genes that may be linked to severe preeclampsia, a serious pregnancy condition. By comparing women with severe preeclampsia to those with normal pregnancies, researchers hope to find clues that could lead to better prevention or treatment.
This trial studies whether using specific blood-pressure medicines can help people with non-severe preeclampsia stay pregnant longer. It aims to improve outcomes by treating blood pressure early while monitoring you and the baby closely.
This trial compares two blood pressure targets for pregnant people with gestational hypertension or preeclampsia without severe features. It aims to find whether a lower target (under 140/90) is better than a higher target (under 160/110) for the health of the mother and baby.
This trial studies how certain blood markers and brain-wave signals change in pregnant people with severe preeclampsia, especially when it leads to eclampsia (seizures). The goal is to better understand warning signs and treatment response to keep mother and baby safer.
This study looks at whether certain blood tests can help doctors manage high blood pressure after delivery in people with severe preeclampsia. It compares the usual care with additional blood tests to see if they improve recovery and reduce complications.
This study tests whether treating mild high blood pressure early in pregnancy (before 20 weeks) can improve outcomes for you and your baby. It compares taking medication versus monitoring without medication.
Hear when a new Severe Preeclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.